Bergenin CAS 477-90-7

130640

Synonyms: (-)-Bergenin, Ardisic acid B, Bengenin, Bergeninum, Bergenit, Corylopsin, Cuscutin, Peltophorin, Vakerin

Download quality specification Bergenin-CAS-477-90-7-QS.pdf

250 g € 220
500 g € 340
1 kg € 620
2 kg € 1150
For bulk quantities contact us at [email protected]
Cat. No. NST-10-194
CAS 477-90-7
Purity 98% (HPLC)
Appearance White powder
Molecular formula C14H16O9
Molecular weight 328,27
Storage +2 … +8 °C

Certificate of analysis available by request to [email protected]

SKU: N/A Categories: ,
Description

Bergenin: Unveiling Nature’s Multifaceted Isocoumarin

1. Molecular Identity

  • Chemical Name: (2R,3S,4S,4aR,10bS)-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxy-3,4,4a,10b-tetrahydro-2H-pyrano[3,2-c]isochromen-6-one
  • CAS Number: 477-90-7
  • Source: Found in various plant species, notably Bergenia crassifolia and Ardisia japonica

2. Biochemical Significance

Bergenin is a C-glycoside of 4-O-methyl gallic acid, possessing a unique isocoumarin structure. Its diverse pharmacological activities have made it a compound of significant interest in natural product research and potential therapeutic applications.

3. Key Therapeutic Properties

  • Antioxidant: Exhibits potent free radical scavenging activity
  • Anti-inflammatory: Demonstrates ability to modulate inflammatory pathways
  • Hepatoprotective: Shows potential in protecting liver cells
  • Neuroprotective: Indicates promise in supporting neuronal health

4. Potential Applications

  • Antioxidant research and formulations
  • Inflammatory disorder studies
  • Liver disease investigations
  • Neurodegenerative disease research

5. Current Research Focus

Ongoing studies are investigating Bergenin’s effects on:

  • Oxidative stress-related disorders
  • Chronic inflammatory conditions
  • Liver fibrosis and hepatotoxicity
  • Neurological disorders and cognitive function

6. Formulation Challenges and Innovations

Researchers are actively working on:

  • Enhancing bioavailability through novel delivery systems
  • Developing stable formulations for various applications
  • Creating synergistic combinations with other bioactive compounds

7. Regulatory Considerations

As a naturally occurring compound, Bergenin’s (CAS 477-90-7) regulatory status is evolving. Its use in specific therapeutic applications would require comprehensive safety and efficacy evaluations to meet regulatory standards.

8. Future Directions

The scientific community anticipates:

  • Advanced clinical trials for specific health indications
  • Exploration of Bergenin’s potential in combination therapies
  • Development of semi-synthetic derivatives with enhanced properties

9. Collaborative Opportunities

We invite researchers, pharmaceutical companies, and academic institutions to explore the therapeutic potential of Bergenin. For inquiries, collaborations, or to discuss how Bergenin can benefit your research or product development, please contact us at [email protected].

Join us in unlocking the full potential of Bergenin – a promising natural compound at the forefront of antioxidant and anti-inflammatory research.